Les Risques Biotechnologiques: État de la Question dans l'Industrie Agroalimentaire Canadienne

Éric Clément and Caroline Debuissy

CIRANO Project Reports from CIRANO

Abstract: This document sums up the technological, economical, biological and statutory aspects of products issued from Canadian biotechnology, used in the fields of agribusiness, and commonly called GMO (Genetically Modified Organisms). A first section analyses the different terms (and their nuances) used in this field. A second section studies the expansion of Canadian industries in biotechnology, as well as the added values of the GMO, the characteristics of the expansion of these firms, the market of the GMO, together with the intellectual property prevailing in these industries. A third section on biology explains the stages in manufacturing transgenetic organisms. Another section tackles the uncertainties of GMO manufacture, which accounts for the risks and limits of transgenesis for health, environment and economy. This document concludes with a part on regulation and its underlying principles. To download the executive summary of the report (in French), click Keywords: GMO, agribusiness, modern biotechnology, transgenesis, genetic patent, risks, health, Intellectual property, OGM, agroalimentaire, biotechnologie moderne, transgenèse, brevetage du vivant, risques, santé, environnement, propriété intellectuelle

Date: 2002-01-01
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://cirano.qc.ca/files/publications/2002RP-02.pdf

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cir:cirpro:2002rp-02

Access Statistics for this paper

More papers in CIRANO Project Reports from CIRANO Contact information at EDIRC.
Bibliographic data for series maintained by Webmaster ().